The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab combined with weekly paclitaxel carboplatin in first-line in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible for cisplatin-based therapies.
 
Jerome Fayette
Honoraria - AstraZeneca; Bristol-Myers Squibb; Hookipa Pharma; Merck Serono; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Elevar Therapeutics; Hookipa Pharma; ITeos Therapeutics; Merck Serono; Merck Sharp & Dohme; Seagen
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Claire Cropet
No Relationships to Disclose
 
Julien Gautier
No Relationships to Disclose
 
Clemence Toullec
Honoraria - Amgen; Bayer; Bristol-Myers Squibb/Celgene; Ipsen; MSD; Pierre Fabre; Sanofi; SERVIER
Consulting or Advisory Role - AstraZeneca; Merck Serono
Research Funding - Bristol-Myers Squibb/Medarex (Inst)
Travel, Accommodations, Expenses - Accord Healthcare; Amgen; AstraZeneca; Bristol-Myers Squibb/Celgene; Ipsen; Merck Serono; Merck Serono; Sanofi; SERVIER
 
Mickael Burgy
Honoraria - MSD
Consulting or Advisory Role - Lilly O.
 
Amandine Bruyas
Travel, Accommodations, Expenses - Eisai; Merck
 
Christian Sire
Consulting or Advisory Role - AstraZeneca; Janssen
 
Aurelie Lagrange
No Relationships to Disclose
 
Florian Clatot
Honoraria - AstraZeneca; AstraZeneca; BMS; BMS; BMS; Merck; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD
Consulting or Advisory Role - BMS; Lilly; Lilly; Merck Serono; Merck Serono; MSD; Novartis; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; BMS; Merck Serono; Novartis; Novartis; Pfizer; Roche
 
Benoit Calderon
No Relationships to Disclose
 
Marie Vinches
No Relationships to Disclose
 
Mariana Iacob
No Relationships to Disclose
 
Laurent Martin
No Relationships to Disclose
 
Eve Marie Neidhardt Berard
No Relationships to Disclose
 
Marie-Christine Kaminsky
No Relationships to Disclose
 
Damien Vansteene
Honoraria - Astellas Pharma; Merck; Theradial
 
Sébastien Salas
No Relationships to Disclose
 
Anne Champagnac
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca; BMS; DAIICHI SANKYO; Lilly; MSD; Novartis; Roche; TAKEDA
Travel, Accommodations, Expenses - Roche
 
Jean Bourhis
No Relationships to Disclose